For decades, scientists have been defeated in their attempts to find a treatment that effectively reverses the life-threatening damage caused by heart attacks.
Now scientists at Novo Biosciences have identified the first and only drug candidate shown to stimulate a damaged heart to repair itself.
Our scientists use a unique, rapid and cost-effective strategy to develop breakthrough drugs to regenerate damaged organs and tissues. These drugs spur the body to heal itself by triggering powerful mechanisms of self-repair and regrowth that lie dormant in our genes. It’s a bold, new approach with the potential to transform the way we treat human disease.
It takes unconventional thinking to change the future.
Novo Biosciences is leading the way.
Media & Press
Novo Biosciences Inc. has announced that it has received a two-year, $1.5 million Small Business Innovation Research (SBIR) grant from the National Institutes of...Read more
Looking beyond stem cells and tissue engineering: What if lost and damaged tissues and organs could be regenerated simply by taking a drug?
While stem cell and tissue engineering approaches may ultimately deliver on their clinical promise, small molecules that control innate regeneration mechanisms offer...Read more
US researchers claim to have identified a groundbreaking drug that could restore heart muscle function following a heart attack. A new study describes how MSI-1436...Read more
A federal patent has been awarded to scientists at Novo Biosciences, a step that will allow research to proceed on a molecule that shows promise in helping heart...Read more